Neos Therapeutics Raises $13.5M

Grand Prarie-based Neos Therapeutics, a contract biopharmaceuticals manufacturer, has raised $13.5M in a funding round, according to a recent regulatory filing by the firm. Source of the new funding was not disclosed. The filing indicates the $13.5M is part of an ongoing $20M funding round for the company. Neos Therapeutics's prior investors include Burril & Company, CAC, CMEA Capital, Essex Capital Corporation, Delaware Street Capital, and Legacy Capital Partners. More information »